Signum Dermalogix, Inc.
PrivateLast Round
Series C
Jul 28, 2026
Total Funding Raised
$29.6M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Signum Dermalogix, Inc. is a biopharmaceutical and skincare company that develops clean, minimalist formulations and patented active ingredients for the professional dermatology and medspa market under the brand name Epicutis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Fashion & Beauty, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Signum Dermalogix, Inc. Comparables
Compare Signum Dermalogix, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Senté | 82% | |
| Topix Skin Health | 75% | |
| Colgate-Palmolive Co. | 75% |
Signum Dermalogix, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 28, 2026 | ||||
| VC Round | Jun 30, 2025 | ||||
| Grant | Feb 15, 2017 | ||||
| Grant | Nov 14, 2013 | ||||
| Grant | Jul 8, 2013 |
Signum Dermalogix, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| GroundForce Capital | Series C |
| National Institute of Allergy and Infectious Diseases | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
$25M round led by GroundForce Capital.
- Jun 30, 2025
Raised $10M in a VC Round.
Signum Dermalogix, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Signum Dermalogix, Inc.'s valuation, stock price, and market status.
Is Signum Dermalogix, Inc. a public or private company?
Signum Dermalogix, Inc. is a private company.
What is the current stock price of Signum Dermalogix, Inc.?
Signum Dermalogix, Inc. is a private company, so its shares have no public market price. Caplight tracks Signum Dermalogix, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Signum Dermalogix, Inc. worth (valuation)?
Valuation information for Signum Dermalogix, Inc. is not publicly available.
Can I buy Signum Dermalogix, Inc. stock?
Signum Dermalogix, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Signum Dermalogix, Inc.'s last funding round?
Signum Dermalogix, Inc.'s most recent funding round was Series C on July 28, 2026.
Who are the main investors in Signum Dermalogix, Inc.?
Key investors in Signum Dermalogix, Inc. include GroundForce Capital.
Will Signum Dermalogix, Inc. IPO soon?
No public IPO plans have been announced for Signum Dermalogix, Inc..
How can I track Signum Dermalogix, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Signum Dermalogix, Inc.'s shares on secondary markets.